Table 1.
Recommended antibiotic treatment according to Jalan et al. [3]
Site of infection | Community-acquired | Nosocomial |
---|---|---|
SBP, SBE, spontaneous bacteremia | cefotaxime or ceftriaxone or amoxicillin/clavulanic acid | piperacillin/tazobactam or meropenem ± glycopeptide |
Urinary tract infection |
uncomplicated: ciprofloxacin or cotrimoxazole sepsis: cefotaxime or ceftriaxone or amoxicillin/clavulanic acid |
uncomplicated: Nitrofurantoin or fosfomycine sepsis: Piperacillin/tazobactam or meropenem ± glycopeptide |
Pneumonia | amoxicillin/clavulanic acid or ceftriaxone + macrolide or levofloxacin or moxifloxacin |
piperacillin/tazobactam or meropenem/ceftazidime + ciprofloxacin glycopeptides when high risk for MRSA |
Cellulitis | amoxicillin/clavulanic acid or ceftriaxone + oxacillin | meropenem/ceftazidime + oxacillin or glycopeptides |
MRSA = Methicillin-resistant Staphylococcus aureus; SBE = spontaneous bacterial empyema; SBP = spontaneous bacterial peritonitis.